The pharmacovigilance industry, is growing at a rate of 9.5% by the end of this decade, to reach USD 15,259.8 million by 2030. The growth of the industry is powered by the rising concerns about drug safety, increasing incidence of toxicity and adverse drug reactions, and a focus on drug efficacy. Moreover, government and non-government organizations are highly attentive toward … Continua a leggere→